Rudek, Michelle A <br/><br/>
In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 2005 
 - 8503-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-05-1037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--metabolism<br/>Administration, Oral<br/>Animals<br/>Chromatography, High Pressure Liquid<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Drug Therapy, Combination<br/>HIV Protease Inhibitors--pharmacology<br/>Humans<br/>In Vitro Techniques<br/>Mass Spectrometry<br/>Methylurea Compounds--blood<br/>Mice<br/>Microsomes, Liver--drug effects<br/>Neoplasm Proteins--metabolism<br/>Ritonavir--pharmacology<br/>Substrate Specificity<br/>Tubulin--metabolism